| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 07/30/2008 | CN101233112A Benzoquinazoline derivatives and their use in treating bone disorders |
| 07/30/2008 | CN101230042A Uracil weeding compounds introducing amide structure |
| 07/30/2008 | CN101230036A Method for preparing heterocyclic aryl-aryl biphenyl compounds |
| 07/30/2008 | CN101230015A Substituted cinnamic acid derivatives containing amine substituent group and expression purification cytotoxicity thereof |
| 07/30/2008 | CN101229165A Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 07/30/2008 | CN100406453C 4-anilino-quinazoline derivatives as antiproliferative agents |
| 07/29/2008 | US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 07/29/2008 | US7405221 2-(4-fluorobenzyloxy)-4-(2,4-dichlorophenyl)-5-(4-chlorophenyl)pyrimidine; antagonists or inverse agonists of the Cannabinoid-1 (CB1) receptor; antidepressant, neuroleptic, anxiolytic, antiinflammatory agent, cognition activator; psychosis, epilepsy, Parkinson's disease, and schizophrenia |
| 07/29/2008 | US7405220 Pyrazolopyrimidines |
| 07/29/2008 | US7405214 Antitumor agents; 2-fluoro-cyclopentenyl nucleosides such as 4-Amino-1-(2-fluoro-4-hydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one; synthesis using 1-((4S,5S)-2,2-Dimethyl-5-vinyl-1,3-dioxolan-4-yl)-2-trityloxy-ethanone intermediates |
| 07/29/2008 | CA2438813C Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 07/29/2008 | CA2178174C Process and intermediates for the manufacture of herbicidal 1-{[2-(cyclopropylcarbonyl)phenyl]sulfamoyl}-3-(4,6-dialkoxy-2-pyrimidinyl)urea compounds |
| 07/29/2008 | CA2168192C 4-aminobenzoylguanidine derivatives |
| 07/25/2008 | CA2617463A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/24/2008 | WO2008089459A1 Inhibitors of mek |
| 07/24/2008 | WO2008088727A2 Endothelin receptor antagonists |
| 07/24/2008 | WO2008087021A1 Synthesis of 4-amino-pyrimidines |
| 07/24/2008 | WO2008086931A1 Dithiolene metal complex colorless ir absorbers |
| 07/24/2008 | WO2008086730A1 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis |
| 07/24/2008 | WO2008055068A8 Inhibitors of histone deacetylase |
| 07/24/2008 | WO2007120638A3 Methods and compositions for modulating glycosylation |
| 07/24/2008 | US20080177069 Process for producing 4-aminoquinazoline compound |
| 07/24/2008 | US20080177068 Quinazole derivatives |
| 07/24/2008 | US20080177064 Dipeptidyl peptidase inhibitors |
| 07/24/2008 | US20080176881 Compounds and compositions as protein kinase inhibitors |
| 07/24/2008 | US20080176880 Activity against strains having acquired resistance nonnucleoside reverse transcriptase inhibitors; human alpha1 acid glycoprotein nonbinding; such as 4-[[(5-bromo-4,6-dichloro)-2-pyrimidinyl]amino]-benzonitrile |
| 07/24/2008 | US20080176878 Crystalline rosuvastatin calcium |
| 07/24/2008 | US20080176876 Substituted 2-Alkyl Quinazolinone Derivatives as Parp Inhibitors |
| 07/24/2008 | US20080176875 Substituted quinazolines |
| 07/24/2008 | US20080176869 e.g. N-(4-fluorobenzyl)-3-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-2-carboxamide; viricide in combination with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; AIDS |
| 07/24/2008 | US20080176867 e.g., N-[[5-(4-bromophenyl)-4-(2,4-dichlorophenyl)pyrimidin-2-yl]methyl]-3-(trifluoromethyl)benzenesulfonamide; cannabinoid receptor modulator; metabolic and gastrointenstinal disorders, antidiabetic, antiinflammatory, analgesic agent; neurodegenerative diseases |
| 07/24/2008 | US20080176866 3-(5-Bromo-2-{4-[5-bromo-4-((1R,2R)-2-hydroxy-1-methyl propylamino)-pyrimidin-2-ylamino]phenylamino}pyrimidin-4-ylamino)butan-2-ol; cell cycle and tyrosine kinase receptor inhibitor; antiproliferative, anticarcinogenic agent |
| 07/24/2008 | US20080176860 8-[4-{4-[5-(Acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2-fluoro-phenoxymethyl}-4-(3,4,5,6-tetrahydroxy-tetrahydro-pyran-2-carbonyloxy)-piperidin-1-yl]-1-cyclopropyl-7-fluoro-9-methyl; microbioside; multi-drug resistant bacteria; bacterial topoisomerases and protein synthesis inhibitor |
| 07/24/2008 | US20080176833 Dihydropyridine derivatives as useful as protein kinase inhibitors |
| 07/24/2008 | US20080176830 Compounds, Compositions, and Methods |
| 07/24/2008 | US20080176813 Carbocyclic nucleosides and process for obtaining such |
| 07/24/2008 | US20080176744 Use of 4-Aminopyrimidines for Controlling Harmful Fungi, Novel 4-Aminopyrimidines, Processes for Their Preparation and Compositions Comprising Them |
| 07/24/2008 | US20080175814 Quinoline derivatives for modulating dna methylation |
| 07/24/2008 | CA2712073A1 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 07/24/2008 | CA2675358A1 Inhibitors of mek |
| 07/23/2008 | EP1947103A1 Aryloxypropanolamines, methods of preparation thereof and use of aryloxypropanolamines as medicaments |
| 07/23/2008 | EP1947092A1 Nucleic acid base having perfluoroalkyl group and method for producing the same |
| 07/23/2008 | EP1947091A1 Pyrimidyl nitrile derivatives as cysteine protease inhibitors |
| 07/23/2008 | EP1947086A1 Benzene derivative or salt thereof |
| 07/23/2008 | EP1945627A1 Pyrimidine derivatives for the treatment of cancer |
| 07/23/2008 | EP1945213A2 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 07/23/2008 | EP1368413B1 Two-layer imageable element comprising thermally reversible polymers |
| 07/23/2008 | EP1325745B1 Preventives and remedies for complications of diabetes |
| 07/23/2008 | EP1315715B1 Quinazoline derivatives as kinase inhibitors |
| 07/23/2008 | EP1080092B1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 07/23/2008 | EP1073638B1 Heterocyclically substituted amides, their production and their use |
| 07/23/2008 | CN101228136A 2-cyano-pyrimidines and -triazines as cysteine protease inhibitors |
| 07/23/2008 | CN101228129A Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls |
| 07/23/2008 | CN101225083A Tetrahydro quinazoline ketone compound and use thereof in preparation of medicine treating and preventing virus diseases |
| 07/23/2008 | CN101223883A Weedicide compound of water dissolved saline of novel structure sulfonylurea compound |
| 07/23/2008 | CN100404537C Quinazolin allkaloids compound, preparation method and use thereof |
| 07/23/2008 | CN100404517C Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 07/23/2008 | CN100404032C Novel crystalline forms of the anti-cancer compound ZD1839 |
| 07/22/2008 | US7402589 such as 1-(4-Fluorophenyl)-1-{2-[(1S)-2-hydroxy-1,2-dimethyl-propylamino]-pyrimidin-4-yl}-3-o-tolyl-urea; Interleukin-1, Cycloxygenase-2, Tumor Necrosis Factor- alpha antagonist; antiinflammatory agent; rheumatoid arthritis or osteoarthritis |
| 07/22/2008 | US7402586 3-Benzylsulfonylamino-6-methyl-1-[(3-guanidinooxypropyl)aminocarbonylmethyl]-2-pyridinone trifluoroacetate; anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 07/22/2008 | US7402585 For example, 2-(3-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)-N-phenylacetamide; use in the treatment of certain diseases, in particular to proliferative disease such as cancer |
| 07/22/2008 | US7402557 Reducing epithelial toxicity such as a skin rash or diarrhea during cancer therapy, by coadministering KGF with erlotinib (N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazoline amine) |
| 07/17/2008 | WO2008086462A2 AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS |
| 07/17/2008 | WO2008084872A1 Hydrazone derivative |
| 07/17/2008 | WO2008084493A2 A novel process for the preparation of 2-halo-4-aminoquinazolines |
| 07/17/2008 | WO2008067440A3 Rosuvastatin dehydroabietylamine salt |
| 07/17/2008 | WO2008067219A3 Quinazolinone modulators of tgr5 |
| 07/17/2008 | US20080171878 Dealkoxycarbonylating a 4-oxo-1,6-dihydro-pyrimidinyl carboxylic acid ester; one-pot procedure, without isolation of intermediate |
| 07/17/2008 | US20080171877 N-(4-Heptadecyl-6-oxo-1,6-dihydropyrimidin-2-yl)-N'-phenylguanidine; low viscosity values at the jetting temperature of a hot melt ink jet printer |
| 07/17/2008 | US20080171876 3-[2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-1-piperidyl]ethyl]-7-hydroxy-4-methyl-1,5-diazabicyclo[4.4.0]deca-3,5-dien-2-one, with less than 0.2% of the impurity 3-[2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-1-oxypiperidin-1-yl]ethyl]-7-hydroxy-4-methyl-1,5-diazabicyclo[4.4.0]deca-3,5-dien-2-one |
| 07/17/2008 | US20080171875 Process for the synthesis of 9-hydroxy risperidone (paliperidone) |
| 07/17/2008 | US20080171874 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 07/17/2008 | US20080171756 e.g. N-{[4-hydroxy-6-oxo-2-phenyl-1-(phenylmethyl)-1,6-dihydro-5-pyrimidinyl]carbonyl}glycine; anemia caused by increasing the production of erythropoietin (Epo), ischemia, stroke, and cytoprotection |
| 07/17/2008 | US20080171742 e.g. 6-methyl-2-{2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(pyrid-2-ylamino)pyrimidine; insulin-like growth factor 1 receptor (somatomedin) antagonist; antiproliferative, antitumor, anticarcinogenic agent; |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/16/2008 | EP1944298A1 Quinazoline derivative and pharmaceutical |
| 07/16/2008 | EP1944289A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 07/16/2008 | EP1943240A2 Chemical process |
| 07/16/2008 | EP1943233A2 Compounds and compositions for protein kinase inhbitors |
| 07/16/2008 | EP1943232A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 07/16/2008 | EP1943213A2 Ppar modulating biaromatic compounds |
| 07/16/2008 | EP1942905A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/16/2008 | EP1660445A4 Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| 07/16/2008 | EP1392655B1 Potassium channel openers |
| 07/16/2008 | EP1054004B1 Novel pyrimidine-5-carboxamide derivatives |
| 07/16/2008 | CN101223147A Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 07/16/2008 | CN101223146A Modulators of ATP-binding cassette transporters |
| 07/16/2008 | CN101219999A N- (3-ethynylphenyl) -6, 7-bis (2-methoxyethoxy) -4-quinazolinamine mesylate anhydrate and monohydrate |
| 07/16/2008 | CN101219998A Acyclic pyrimidine nucleoside derivant and method for producing the same |
| 07/16/2008 | CN101219997A Synthesis of 2-chlorine-5- amido pyrimidine |
| 07/16/2008 | CN101219987A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same |
| 07/16/2008 | CN100402627C C-nitrosoaniline compounds and their blends as polymerization inhibitors |
| 07/16/2008 | CN100402515C Substituted phthalides as anti-convulsive drugs |
| 07/16/2008 | CN100402506C Ozagrel lysine, preparing method and usage |
| 07/16/2008 | CN100402495C Aminoalkylamide substituted cyclohexyl derivatives |
| 07/15/2008 | US7399884 Substituted benzamides; anticarcinogenic agents, antiinflammatory agents, antiarthritic agents, transplant rejection; controlled release formulations |
| 07/15/2008 | US7399856 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrile |
| 07/15/2008 | US7399775 β-amyloid protein production/secretion inhibitor |
| 07/15/2008 | US7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |